E.Merge Technology Acquisition Corp. Announces Liquidation For ~$10.06/Share

E.Merge Technology Acquisition Corp. (NASDAQ:ETAC) (the "Company") announced today that, due to its inability to consummate an initial business combination within the time period required by its Second Amended

E.Merge Technology Acquisition Corp. (NASDAQ:ETAC) (the “Company”) announced today that, due to its inability to consummate an initial business combination within the time period required by its Second Amended and Restated Certificate of Incorporation, as amended (the “Amended Charter”), the Company intends to dissolve and liquidate in accordance with the provisions of its Amended Charter, effective as of the close of business on September 4, 2022, and will redeem all of the outstanding shares of Class A common stock that were included in the units issued in its initial public offering (the “Public Shares”), at a per-share redemption price of approximately $10.06.

Total
0
Shares
Related Posts
Read More

Reported Late Thursday, AVEO Oncology Stockholders Approve Acquisition By LG Chem; AVEO Stockholders Will Receive $15.00 Per Share In Cash Upon The Closing Of The Transaction

AVEO Oncology ("AVEO") (NASDAQ:AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, announced that at a special meeting of stockholders (the "Special Meeting") held today, AVEO stockholders approved th

AVEO